Abstract

Background and case: An adolescent male presented with a second mediastinal tumor 1.5 years after treatment of a proven malignant germ-cell tumor in that location. The differential diagnosis included a recurrent germ-cell tumor or a non-germ cell malignancy. Serum tumor markers alpha-fetoprotein (AFP) and human chorionic gonadotrophin (HCG) were negative. The first biopsy was not informative, and the second biopsy gave a broad differential diagnosis including secondary non-germ cell malignancy using histology and immunohistochemistry. DNA methylation profiling, RNA sequencing, and targeted microRNA371a-3p profiling was subsequently performed, without a supportive result. After resection of the tumor the definitive diagnosis yielded two secondary non-germ cell malignancies in the form of a leiomyosarcoma and a solitary neuro endocrine carcinoma (NEC). In spite of the differences between the molecular profiles of the initial germ-cell tumor, the leiomyosarcoma and large-cell NEC are clonally related, as determined by the presence of identical chromosomal breakpoints. The copy number profiles suggest an initial polyploidization step, followed by various independent chromosomal gains and losses. This case demonstrates that germ-cell tumors must be evaluated carefully, including molecularly, in which the non-germ cell malignancy is negative for miR-371a-3p, both in tissue as well as in serum, in contrast to the primary tumor. We conclude that the patient presented with a primary type II mediastinal GCT and, a year and a half later, followed by a leiomyosarcoma and a large-cell NEC presenting as two secondary somatic-type malignancies clonally related to the original GCT. Conclusions: Malignant germ-cell tumors are known to recur as a somatic-type malignancy in very rare cases. This case report illustrates the challenges faced in defining the nature and clonality of the secondary somatic-type malignancies.

Highlights

  • Serum tumor markers (STMs) are only reliable when restricted subtypes are represented in the GCT, especially related to AFP and human chorionic gonadotrophin (HCG) for YST and choriocarcinoma, respectively [5]

  • Radiological findings combined with STMs may point at a diagnosis, but in case of a negative marker status, a biopsy is required for a histopathological diagnosis [3]

  • No clinically informative STMs are available for non-germ cell malignancies, which is a major limitation in their management to date

Read more

Summary

Background

Malignant GCTs are classified into germinoma-like (including seminoma and (dys)germinoma) and nongerminomatous tumors (yolk sac tumor [YST], choriocarcinoma, embryonal carcinoma [EC] and teratoma). This group of heterogeneous neoplasms is unique in that their developmental potential is, in effect, determined by the latent potency state of their cells of origin, which are reprogrammed to omnipotent/totipotent or pluripotent stem cells [2,4]. We describe a patient with a history of an initially STM-positive mixedmalignant (type II) mediastinal GCT, composed histologically of seminoma, EC, YST and teratoma. The tumor was diagnosed as two secondary somatic-type malignancies with the histology of leiomyosarcoma and a large-cell NEC, demonstrated to be clonally related to the primary tumor, in spite of heterogeneous chromosomal copy number profiles but a common breakpoint

Clinical Description and Histological Findings
Hematoxylin-eosin of of thethe primary mediastinal germ-cell tumor:
Immunohistochemistry
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call